| 000 | 01635 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515055116.0 | ||
| 264 | 0 | _c20070405 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a0953-816X | ||
| 024 | 7 |
_a10.1111/j.1460-9568.2006.05285.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlandini, Fabio | |
| 245 | 0 | 0 |
_aTime-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. _h[electronic resource] |
| 260 |
_bThe European journal of neuroscience _cJan 2007 |
||
| 300 |
_a397-405 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasal Ganglia _xdrug effects |
| 650 | 0 | 4 |
_aBehavior, Animal _xclassification |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCytochromes c _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aLevandis, Giovanna | |
| 700 | 1 | _aBazzini, Eleonora | |
| 700 | 1 | _aNappi, Giuseppe | |
| 700 | 1 | _aArmentero, Marie-Therese | |
| 773 | 0 |
_tThe European journal of neuroscience _gvol. 25 _gno. 2 _gp. 397-405 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2006.05285.x _zAvailable from publisher's website |
| 999 |
_c16844610 _d16844610 |
||